Shikimic acid is a cyclohexenecarboxylic acid intermediate in the biosynthesis of aromatic amino acids in plants and microorganisms. Shikimic acid is also a precursor in the synthesis of oseltamivir. It decreases lipid droplet accumulation, increases the levels of phosphorylated AMPK, and decreases the levels of MID1IP1. Shikimic acid increases differentiation of oligodendrocyte precursor cells in vitro. It decreases inflammation and demyelination in a mouse model of experimental autoimmune encephalomyelitis (EAE) and induces remyelination in a model of focal demyelination induced by L-α-lysophosphatidylcholine (LPC) in mouse dorsal spinal cord.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.